USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: CELLASIC CORPORATION
City: Hayward
State: CA
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,441,758.00 5
SBIR Phase II $3,182,172.00 4

Award List:

Microfluidic System for Automated Cell Toxicity Screening

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Philip J. Lee
Award Amount: $105,000.00
Abstract:
DESCRIPTION (provided by applicant): The main objective of this proposal is to develop a microfluidic platform for cancer drug toxicity screening in cultured human cells. While it is believed that improved information on a patient's individual cancer signature can aid diagnosis and treatment, the… More

Microfluidic Bioreactor for High Throughput Cell-based

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul J. Hung
Award Amount: $199,700.00
Abstract:
DESCRIPTION (provided by applicant): The grant application proposes the development of an SBS standard thermoplastic (PMMA) microfluidic bioreactor for high throughput continuously perfused cell-based screening for the pharmaceutical and biotechnology industry. More specifically, the 1- year Phase I… More

Continuous Perfusion Cell Microarray for In Vitro Toxicity Screening

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul J. Hung
Award Amount: $135,250.00
Abstract:
DESCRIPTION (provided by applicant): The main objective of this proposal is to develop and deliver a high density continuous perfusion cell microarray to enable high throughput and high quality cell-based screening for the pharmaceutical and biotechnology industry. More specifically, the 6-month… More

Microfluidic Cell Culture Array for Predictive Toxicity Screening

Award Year / Program / Phase: 2007 / SBIR / Phase II
Agency: HHS
Principal Investigator: Paul J. Hung
Award Amount: $800,039.00
Abstract:
DESCRIPTION (provided by applicant): The main objective of the Phase II proposal is to further develop the microfluidic cell culture array for high quality cell-based life science applications in the pharmaceutical and biotechnology industry. This will foc us on predictive hepatotoxicity screening,… More

Microfluidic Bioreactor for High Throughput Hepatotoxicity Screening

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: HHS
Principal Investigator: Paul J. Hung
Award Amount: $684,258.00
Abstract:
DESCRIPTION (provided by applicant): The main objective of the Phase II proposal is to commercialize the SBS standard format microfluidic bioreactor array developed in Phase I for high throughput physiologic cell-based screening in the pharmaceutical and b iotechnology industry, with special focus… More

Microfluidic Platform for Cancer Cell Culture and Analysis

Award Year / Program / Phase: 2008 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $897,100.00
Abstract:
DESCRIPTION (provided by applicant): This Phase II SBIR proposes to develop a microfluidic cell culture and analysis platform for the in vitro screening of cancer cells. The end result of this research will be to deliver a fully functional system (automate d instrument and disposable microfluidics)… More

Microfluidic Liver Array for Drug Metabolite Profiling

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul J. Hung
Award Amount: $896,600.00
Abstract:
DESCRIPTION (provided by applicant): CellASIC has developed a novel microfluidic technology to integrate 32 bioreactors on a standard 96-well plate for multiplexed perfusion culture of primary human hepatocytes with demonstrated long-term viability and li ver-enzymatic function. This Phase 1 SBIR… More

Microfluidic Liver Array for Long Term In Vitro Hepatocyte Culture and Screening

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Philip J. Lee
Award Amount: $105,208.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this proposal is to complete development of a Microfluidic Liver Array (MLA) platform for improved and lower cost in vitro toxicity screening targeting the human liver. This funding will directly lead to the commercialization of a product with … More

Microfluidic Liver Array for Long Term In Vitro Hepatocyte Culture and Screening

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Philip J. Lee – 510-785-9846
Award Amount: $800,775.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this proposal is to complete development of a Microfluidic Liver Array (MLA) platform for improved and lower cost in vitro toxicity screening targeting the human liver. This funding will directly lead tothe commercialization of a product with … More